A Single-Center, Randomized, Double-Blind, 3-Period Cross-Over Trial to Compare the Effect of Insulin Glulisine, Insulin Lispro and Unmodified Human Insulin on the Endogenous Glucose Production in Type 1 Diabetic Patients.

Trial Profile

A Single-Center, Randomized, Double-Blind, 3-Period Cross-Over Trial to Compare the Effect of Insulin Glulisine, Insulin Lispro and Unmodified Human Insulin on the Endogenous Glucose Production in Type 1 Diabetic Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2009

At a glance

  • Drugs Insulin; Insulin glulisine; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 17 Dec 2009 Actual initiation date (Apr 2004) added as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual end date (May 2004) added as reported by ClinicalTrials.gov.
    • 12 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top